共 164 条
[1]
Passaroni AC(2015)Cardiopulmonary bypass: development of John Gibbon's heart-lung machine Braz J Cardiovasc Surg 30 235-245
[2]
Silva MAM(2012)The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation Int J Immunopharmacol 14 202-208
[3]
Yoshida WB(2014)Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair Br J Anaesth 112 1005-1014
[4]
Schmid E(2004)Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration Anesthesiology. 101 299-310
[5]
Krajewski S(2013)Randomized trial on the effect of sevoflurane on polypropylene membrane oxygenator performance J Cardiothorac Vasc Anesth 27 903-907
[6]
Bachmann D(2014)Use of volatile anesthetics during cardiopulmonary bypass: a systematic review of adverse events J Cardiothorac Vasc Anesth 28 84-89
[7]
Kurz J(2013)Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study Anesthesiology. 98 1315-1327
[8]
Wendel HP(2015)Identification of miRNAs involved in the protective effect of sevoflurane preconditioning against hypoxic injury in PC12 cells Cell Mol Neurobiol 35 1117-1125
[9]
Rosenberger P(2011)The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ Nat Immunol 12 861-869
[10]
Balkau B(2007)Prediction of microRNA targets Drug Discov Today 12 452-458